Close
Nordic 9Nordic 9

Peptomyc (private company)

Spain peptomyc.com
See something wrong or missing? Let us know
Offices:Barcelona
Industry:BiotechHealth servicesManufacturing
Business model:B2B

Peptomyc is a company founded in 2014 and focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 13.91M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Peptomyc

Name Criteria
Germany CatalYm
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France InnovaFeed SAS
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Switzerland Memo Therapeutics
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany AMSilk
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France Xenothera
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Oxford Nanopore Technologies
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Biograil
58%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
Top